MYTREXATE 2.5

MYTREXATE 2.5 contains Methotrexate 2.5 mg, a well-established immunosuppressant and disease-modifying antirheumatic drug (DMARD). It is commonly used for the treatment of rheumatoid arthritis, psoriasis, and certain types of cancer. Methotrexate works by reducing the activity of the immune system and slowing the growth of abnormal cells.

This lower-dose formulation is ideal for precise dose adjustments, especially in chronic autoimmune conditions where gradual titration is essential.

Key Features:
✅ Contains Methotrexate IP 2.5 mg
✅ Ideal for low-dose, long-term therapy
✅ Used in autoimmune disorders like rheumatoid arthritis and psoriasis
✅ Also indicated in some cancers like leukemia
✅ Doctor-trusted treatment backed by clinical research